Skip to content

AdaptHealth AHCO Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin18.3%-1.6pp18.8%-2.1pp19.3%-5.0pp19.4%-3.3pp19.8%-1.5pp
Net margin-2.4%-5.1pp-2.2%-5.0pp2.5%+9.1pp2.5%+23.7pp2.6%+24.1pp
EBITDA margin12.7%-5.9pp13.1%-6.2pp19.6%+9.9pp19.5%+25.7pp18.6%+24.5pp
Free cash flow margin5.8%-2.6pp6.8%-0.5pp6.5%-0.5pp7.1%+2.0pp8.5%+6.8pp
Returns
Return on equity-5.2%-10.8pp-4.6%-10.6pp5.2%+18.4pp5.2%+42.9pp5.6%+44.1pp
Return on assets-1.8%-3.7pp-1.6%-3.6pp1.9%+6.5pp1.8%+16.1pp1.9%+16.1pp
Return on invested capital0.7%-3.9pp1.2%-3.8pp4.2%+5.6pp4.2%+18.5pp4.6%+18.7pp
Efficiency
Asset turnover0.7×0.0×0.7×0.0×0.7×0.0×0.7×+0.1×0.7×+0.1×
Inventory turnover18.6×-3.3×18.1×-2.2×18.6×-1.2×19.1×-2.0×21.9×+1.0×
Liquidity
Current ratio0.9×-0.4×-0.3×1.1×-0.2×1.1×-0.1×1.3×0.0×
Quick ratio0.7×-0.4×0.8×-0.3×0.9×-0.1×0.8×-0.1×1.1×0.0×
Cash ratio0.1×0.0×0.1×0.0×0.1×-0.1×0.1×0.0×0.1×-0.1×
Leverage
Debt-to-equity1.3×0.0×1.3×-0.1×1.2×-0.3×1.2×-0.3×1.3×-0.3×
Debt-to-assets0.5×0.0×0.4×0.0×0.4×-0.1×0.4×0.0×0.5×0.0×
Net debt / EBITDA4.7×+1.3×4.2×+1.0×2.9×-3.7×3.4×
Per Share
Book value per share$11.10-4.6%$11.24-3.1%$11.78+6.1%$11.58+6.0%$11.63+5.8%
Valuation
Market capitalization$1.36B+20.5%$1.35B+5.3%$1.21B-19.1%$1.18B-11.1%$1.46B-4.4%
Enterprise value$3.32B+4.3%$3.15B-4.7%$3.03B-15.1%$3.06B-12.2%$3.51B-7.5%
Price / sales0.4×+0.1×0.4×0.0×0.4×-0.1×0.4×0.0×0.5×0.0×
Price / book0.9×+0.2×0.9×+0.1×0.7×-0.2×0.7×-0.1×0.9×-0.1×
EV / EBITDA7.9×+2.7×7.4×+2.2×4.8×-6.6×4.9×5.8×
EV / sales0.0×0.0×0.9×-0.2×0.9×-0.1×1.1×-0.1×
Free cash flow yield14.1%-10.2pp16.3%-2.1pp17.6%+2.3pp19.6%+7.1pp18.8%+15.3pp
Earnings yield-5.8%-13.4pp-5.2%-12.3pp6.8%+21.1pp6.8%+58.8pp5.8%+51.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are AdaptHealth's profit margins?
AdaptHealth (AHCO) runs a 18.3% gross margin and a 8.0% operating margin, with a -2.4% net margin.
Where do AdaptHealth's ratios come from?
Every ratio is computed from AdaptHealth's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.